about
C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.Inflammatory status and lung function predict mortality in lung cancer screening participants.Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.Lifestyle and breast cancer recurrences: the DIANA-5 trial.A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.High SPARC Expression Starting from Dysplasia, Associated with Breast Carcinoma, Is Predictive for Bone Metastasis without Enhancement of Plasma LevelsTopical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in miceHealth care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy.Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Influence of lignans depletion on murine mammary gland morphology.Role of HER2 in wound-induced breast carcinoma proliferation.Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study.Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/Neu transgenic mice.Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I TrialCpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) productionEffect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening ParticipantsA lipemia-independent NanoDrop®-based score to identify hemolysis in plasma and serum samplesThe Detection and Biological Activity of Human Antibodies to IL-2 in Normal DonorsInduction of Paneth cell degranulation by orally administered Toll-like receptor ligandsInfluence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic MiceRelevance of Antibody Valency in EGF Receptor ModulationIncrease in the therapeutic effect of doxorubicin induced by monoclonal antibodies raised against this drugAn anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drugModulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicinPurification of interleukin-2 antibodies from healthy individualsWeighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS studyMonoclonal antibodies against doxorubicin
P50
Q30238688-F015F1D1-469E-45CE-952C-68FC0B852FBAQ30249664-DBD272A1-D92A-42FE-BFC4-9360DEDF70E9Q30491209-C97D09D1-AE9D-41B0-8168-100AB37D5BACQ33225139-A681E52D-87E3-4A76-9074-EA7375C2004EQ34637407-B6A6B0E0-F043-42ED-89E6-C3D96B9D028AQ34780339-FF35F080-D9B8-4185-BCA4-67A43B50FAA2Q35059203-17DDCA11-37A3-4640-BE78-2D7BACB18F17Q36403906-9BEA0BED-729D-4959-88B3-3F85C27D4751Q36623321-31BE6CC7-078B-42FF-8547-5A945D29BCF3Q39253334-E69C9FFC-A2DD-4248-8C7A-7804424659C3Q39564433-58CE9D14-96FA-4B2B-9978-BC925F1531A1Q40214928-C18EA897-EE91-498F-BCBD-D89136443F52Q41706053-88CC5149-A40C-46DD-AD4A-93987AC67099Q43184864-2DBCB88A-9663-4042-AFD4-108325B7F792Q44558625-C38CFD85-26CE-47EE-AB82-07BFE5A9B35CQ46804967-515E98B9-8DE5-4711-B6EF-E8937A31D1ACQ47293087-D6AB8E5E-D3D8-4A9A-8477-85A81FF37982Q51332682-D3468E5B-85EA-4BFC-8BD8-B00176DB3431Q52574991-46F894E8-EA71-46C0-AF0C-3495C45F36E0Q57081488-FE6F8B90-A4EE-4EEB-8F8B-BA5045E4D25AQ57600505-46275EE0-B8AB-47BC-9AD0-9BAF04317633Q58701296-A5464635-C14B-4207-946A-7AD19E9CD52AQ59340388-56689925-5361-41B8-85AB-85CCF659B225Q61693076-F32FDD59-852D-423B-9C98-F69CC3F44587Q61764594-D2FF63AA-78EA-4681-AD44-899F8107480DQ61764599-C47E80B8-C3A1-479F-8AB4-91D87E633A76Q62604232-4D89BFCE-5B05-4028-99CD-AD7EEB957267Q67561907-F3E8E698-11FE-4D6D-AA1E-763F22479470Q68059976-D01BD7B7-6157-415B-8960-14E9B42E8531Q72284649-F6D670E2-AF26-4329-8071-8B0FAA633B1AQ72921483-90888138-10DC-4CEA-93F7-6D9A9F14CC30Q90045641-8C0D9968-E84F-4FEF-80E2-D3E36CDB4609Q93536968-00BA18FE-D5EE-43C5-AF1F-BF78DD47C924
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniele Morelli
@ast
Daniele Morelli
@en
Daniele Morelli
@es
Daniele Morelli
@fr
Daniele Morelli
@nl
Daniele Morelli
@sl
type
label
Daniele Morelli
@ast
Daniele Morelli
@en
Daniele Morelli
@es
Daniele Morelli
@fr
Daniele Morelli
@nl
Daniele Morelli
@sl
prefLabel
Daniele Morelli
@ast
Daniele Morelli
@en
Daniele Morelli
@es
Daniele Morelli
@fr
Daniele Morelli
@nl
Daniele Morelli
@sl
P1053
I-4113-2017
P106
P1153
7005579970
P21
P31
P3829
P496
0000-0002-1823-3764